High mobility group (HMG) proteins are a family of architectural transcription factors, with HMGA1 playing a role in the regulation of genes involved in promoting systemic inflammatory responses. We speculated that blocking HMGA1-mediated pathways might improve outcomes from sepsis. To investigate HMGA1 further, we developed genetically modified mice expressing a dominant negative (dn) form of HMGA1 targeted to the vasculature. In dnHMGA1 transgenic (Tg) mice, endogenous HMGA1 is present, but its function is decreased due to the mutant transgene.
changes in DNA structure, 6, 7 HMGA1 also recruits nuclear proteins to enhancers, [8] [9] [10] and augments the binding of transcription factors to their binding sites. 2, 11 Our laboratory and others have shown that HMGA1 is vital for the regulation of mouse, [12] [13] [14] rat, 15 and human 16 nitric oxide synthase (NOS)2 in the setting of inflammatory stimuli.
HMGA1 has also been reported to regulate genes involved in the pathobiology of a number of critical illnesses, including mediators that promote proliferation, differentiation, antigen presentation, inflammation, and cancer. [17] [18] [19] Minor groove binding (MGB) drugs, such as Distamycin A and Netropsin, interfere with binding at AT-rich sites in the minor groove of DNA, and are capable of altering gene transcription, in part, by altering the binding of HMGA1 to DNA. 2 By administering MGB drugs systemically, we showed previously that inhibition of HMGA1 binding decreased hypotension and mortality association with the systemic administration of Escherichia (E.) coli LPS (or endotoxin), by reducing expression of NOS2. 20, 21 More recently, we revealed that the effects of MGB drugs on HMGA1 can attenuate tissue inflammation during endotoxemia in vivo 22 by decreasing expression of P-selectin. As MGB drugs (Distamycin A and Netropsin) have antibiotic properties, elucidating the specific role of HMGA1 in microbial sepsis has been more of a challenge.
HMGA1 has been disrupted in mice to explore its function in vivo, however both homozygous and heterozygous mice for the HMGA1 null allele showed cardiac hypertrophy, and the mice developed hematologic malignancies. 23 To overcome these underlying abnormalities, we generated transgenic (Tg) mice overexpressing a dominant-negative (dn) form of HMGA1 (dnHMGA1), which allowed us to further elucidate the importance of HMGA1 not only during a purely proinflammatory and more acute insult of E. coli endotoxemia, but also during a more prolonged microbial sepsis model induced by E. coli fibrin clot. In the Tg mice, endogenous HMGA1 is not absent, however its function is decreased due to overexpression of a mutant transgene. [24] [25] [26] In the present study, Tg mice had a blunted hypotensive response to endotoxemia, and in a model of microbial sepsis, exhibited less mortality. Moreover, Tg mice had a reduced inflammatory response during sepsis, with a prominent decrease in macrophage and neutrophil infiltration into organs. These data suggest that targeted expression of a dnHMGA1 transgene is able to improve outcomes in models of endotoxin exposure and microbial sepsis, with an important component of modulating the immune response.
MATERIALS AND METHODS

Reagents
Murine recombinant IL-1 and TNF-was purchased from PeproTech, Inc. (Rocky Hill, NJ) Escherichia coli LPS (serotype O26:B6) was purchased from Sigma-Aldrich.
Generation of the transgenic construct and mice
To generate the transgenic construct (Fig. 1A) , we used a dnHMGA1 construct containing four proline to alanine substitutions introduced at amino acids 57, 61, 83, and 87 located in the second and third DNAbinding domains (AT-hooks), as described previously. 25 A hemagglutinin (HA) tag was placed on dnHMGA1 construct, in addition to a 300-bp DNA fragment containing bovine growth hormone polyadenylation sequences (bGHpA) that was ligated 3 ′ to the mutated HMGA1 cDNA. The fragment containing dnHMGA1/HA/bGHpA was then ligated downstream of the 2.5 kb mouse aortic carboxypeptidaselike protein (ACLP) promoter. 27, 28 The construct was subsequently injected into the pronuclei of fertilized C57BL/6 mouse eggs (Brigham and Women's Hospital, Core Transgenic Mouse Facility). Two separate injections were performed, generating different lines of mice, and two independent lines of mice (Tg1 and Tg2) were selected for studies after expression of the transgene was confirmed. Transgenic mice harboring the ACLP promoter/dnHMGA1 cDNA were identified by Southern blot analysis 29 using a 32 P-labeled probe from the ACLP promoter, after Sac1 digestion of genomic DNA prepared from tail biopsies (Fig. 1B) .
Southern blotting recognized an endogenous (En) and a transgenic (Tg) fragment (Fig. 1B) . To determine the transgene copy number, radioactivity was measured on a PhosphorImager running ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Transgene copy number was determined by first calculating the ratio of the Tg/En bands, and then multiplying by a factor of 2 (for the two endogenous copies). Tg and littermate WT control mice were used at 8-12 weeks of age.
Cell culture of vascular smooth muscle cells
Primary vascular smooth muscle cells (SMCs) were harvested from WT and Tg mouse aortas, using collagenase and elastase digestion of aortas as described previously. 30 The cells were expanded using DMEM with 20% FBS and Penicillin-Streptomycin-Glutamine.
RNA isolation and RT-PCR analysis
RNeasy Mini RNA isolation kit (Qiagen, Germantown, MD) was used to extract total RNA, according to the manufacturer's instructions, from mouse aortas harvested from WT, Tg2, or Tg1 mice.
After either reverse transcriptase (RT+) to generate complementary DNA from the RNA, or no reverse transcriptase (RT-), PCR was performed using a forward primer from the sequence of HMGA1 (5 ′ -GCCTCCAAGCAGGAAAAGG-3 ′ ) and a reverse primer from the sequence of the HA tag (5 ′ -GGGACGTCGTATGGGTACTG-3 ′ ). 
Western blot analysis
Western immunoblotting was performed as previously described. 32 Briefly, the cells were harvested using RIPA buffer (Tris/Cl 
Transfection assays
Mouse NOS2 luciferase reporter plasmid (base pairs -1485/+31), 33 was transiently transfected into SMCs (FuGENE 6 transfection reagent, Roche Applied Science, Indianapolis, IN), as described previously. 34 The transfection was performed in the presence of the dnHMGA1 expression plasmid (at a ratio of 4:1 to the promoter), or a control plasmid. A -galactosidase expression vector was also cotransfected to normalize for luciferase activity. The cells were treated with IL-1 or vehicle (PBS). Twenty-four hours following treatment, the cells were harvested and assessed for luciferase activity and -galactosidase, as described previously. 21,34
Co-immunoprecipitation assays
Co-immunoprecipitation (co-IP) assays were performed as previously described. 35 In brief, Protein G plus/Protein A-Agarose (Calbiochem, 
Blood pressure analysis
To evaluate blood pressure (BP) of mice, intraarterial catheters were placed in the carotid arteries, as we have performed previously. 20, 36, 37 For studies in mice exposed to endotoxemia (E. coli LPS), the mice were allowed to recover overnight after catheter placement, and mean arterial pressure was assessed following i.p. endotoxin administration (10 mg/kg). The mice then had their blood pressure assessed at serial time points.
Fibrin clot model of peritoneal sepsis in mice
For the fibrin clot model, 28 E. coli bacteria (strain MMB1287) were grown in LB media for 24 h at 37 • C, and 1 ml bacteria were regrown in 9 ml LB media for 3 h at 37 • C. The bacteria were pelleted by centrifugation at 3500 rpm for 10 min, washed in 10 ml PBS twice, and resuspended in 1 ml PBS. The bacteria were diluted in 1% bovine fibrinogen (Sigma-Aldrich, St. Louis, MO), and the final bacterial concentrations of the experiments were 2.2 ± 0.2 × 10 9 cfu/clot.
Human thrombin (Sigma-Aldrich, St. Louis, MO) was added at a final concentration of 2 U/ml, and the mixture was allowed to clot for 10 min. 38 The bacterial concentration in the suspension and the clot was confirmed in each experiment by plating and overnight incubation at 37 • C and counting CFUs. Under ketamine/xylazine anesthesia and sterile conditions, the fibrin clot was placed within the peritoneal cavity of WT and Tg mice via a 1.5 cm abdominal incision that was closed in layers with 6-0 surgical sutures (Harvard Apparatus, Hilliston, MA).
Assessment of bacterial colony forming units and inflammatory cells from peritoneal lavage
WT and Tg mice were sacrificed 24 h after fibrin clot placement, and peritoneal lavage was performed. The peritoneal fluid was assessed for colony forming units (CFUs) of bacteria, and also for total numbers and percentages of macrophages and neutrophils. Serial dilutions were made from an aliquot of peritoneal fluid, and then incubated overnight at 37 • C on LB agar plates and CFUs of bacteria were counted and calculated. 39 Cells from the remaining fluid were stained with antibodies targeting F4/80-APC (BioLegend, Dedham, MA) and Ly6G-PE (BD Biosciences, Franklin Lakes, NJ), to identify macrophages and neutrophils respectively, and were then assessed by flow cytometry using a BD FACS Canto II, and analyzed by FlowJo software.
Phagocytosis assay
In vivo phagocytosis was performed as described. 39 Mice were injected with 5 × 10 6 live GFP-labeled E. coli as described. 
Histology
Mice were sacrificed 24 h following fibrin clot placement, and the spleens and lungs were harvested for histological evaluation. The tissues were fixed in either 10% formalin or methyl Carnoy's solution, processed, embedded in paraffin, and sectioned (5 m Fig. 1 ).
Chemokine/cytokine assay
For MCP-1 and IL-10 analyses of tissue and plasma, samples were assessed using the multiplex assay technology by Luminex as described previously. 41, 42 The levels of MCP-1 and IL-10 were determined by standard curve analysis. The plate was read on a Luminex 200TM instrument (Luminex, Austin, TX). Data acquisition and analysis were conducted using StarStation software v2.3 (Applied Cytometry Systems, Dinnington, U.K.).
Statistical analyses
Data are expressed as mean ± SEM. Comparisons of mortality were made by analyzing Kaplan-Meier survival curves, and then log-rank test to assess for differences in survival. For comparisons between two groups, we used Student's unpaired t-test. One-way or two-way ANOVA was used for analysis of more than 2 groups. When data were not normally distributed, nonparametric analyses were performed using Mann-Whitney U or Kruskal-Wallis testing, respectively. The numbers of samples per group (n), or the numbers of experiments, are specified in the figure legends. Statistical significance is accepted at P < 0.05.
RESULTS
Generation of the dnHMGA1 transgenic mouse
Due to the beneficial effects of blocking HMGA1 binding to DNA by MGB drugs (such as Distamycin A and Netropsin) during F I G U R E 2 NOS2 promoter transactivation and mRNA is suppressed by expression of dnHMGA1. A) SMCs harvested from WT or Tg1 mice were exposed to vehicle (Veh), IL-1 (10 ng/ml, left panel), or TNF-(10 ng/ml, right panel) for various time points (as depicted). Total RNA was extracted from the cells, and levels of NOS2 were measured by qRT-PCR. Data are presented as mean ± SEM, n = 3 per group, with testing by oneway ANOVA (P < 0.0001). Significant comparisons; *WT versus Tg1. (B) SMCs were transiently transfected with a NOS2 luciferase reporter plasmid (base pairs -1485/+31), and either a vector control plasmid or an expression plasmid for dnHMGA1. An expression plasmid for -galactosidase was used to correct for transfection efficiency. Cells were allowed to recover overnight and then the cells were exposed to IL-1 (10 ng/ml) or vehicle for 24 h prior to harvest. Luciferase activity of each group is presented as mean ± SEM, n = 6 per group, with testing by one-way ANOVA (P < 0.0001). Significant comparisons; *versus no (-) IL-1 and no (-) dnHMGA1, and †versus IL-1 (+) and no (-) dnHMGA1. (C) Co-immunoprecipitation assay (co-IP) was performed as described in the Material and Methods. SMCs from WT or dnHMGA1 Tg mice were then harvested and the nuclear protein extracts were incubated with p50 antibody-crosslinked protein A/G beads, rabbit IgG-crosslinked protein A/G beads, or protein A/G beads alone. The bound proteins were separated with SDS-PAGE. Western blot analysis of IP bound proteins (lanes 1 to 4) and pre-IP cellular proteins (lanes 5 and 6) were performed using HA antibody endotoxemia, [20] [21] [22] we hypothesized that overexpression of a mutant HMGA1 transgene incapable of binding to DNA would be beneficial not only in endotoxemia, but also in a mouse model of microbial sepsis. Sepsis is a systemic infectious process disseminated via the blood stream, thus we generated Tg mice using the promoter of aortic carboxypeptidase-like protein (ACLP) to target dnHMGA1 expression in the vasculature. 27 The Tg construct is shown in Fig. 1A , and a full description of the construct is provided in Materials and Methods.
Mutations in the second and third DNA-binding domains of HMGA1 prevent the dominant-negative construct from binding to DNA, 25 thus altering HMGA1 function. The hemagglutinin (HA) tag placed on the construct allows identification of the transgene from endogenous HMGA1. The founder mice were identified by Southern blot analysis of genomic DNA and by PCR (Fig. 1B, arrows) . Analysis of the copy number demonstrated that one line of mice had twice the copy number of the other, from a separate injection of pronuclei, and we designated the dnHMGA1 mice as Tg2 and Tg1 respectively. To confirm mRNA expression of the transgene in Tg mice, total RNA was isolated from aortas of WT, Tg2, and Tg1 mice, and RT-PCR was performed using primers to HMGA1 and the HA tag. The dnHMGA1 transgene was only present in the Tg mice (Fig. 1C) . Also, dnHMGA1 protein was detected in vascular SMCs of Tg mice, but not WT mice, by blotting with an antibody against the HA tag (Fig. 1D) . Moreover, in contrast to the cardiac hypertrophy reported in HMGA1 null mice, 23 dnHMGA1
Tg mice did not exhibit an increase in ratio of heart to body weight in an attenuated transactivation of the NOS2 promoter exposed to IL-1 (Fig. 2B) . While the mutant (dn) HMGA1 construct has been shown previously to not bind to DNA, 25 we wanted to determine whether the dnHMGA1 protein would still be able to interact with transcription factors that contribute to gene regulation. We have previously shown that HMGA1 facilitates NF-B subunit p50 binding to DNA and transactivation of the NOS2 promoter/enhancer. 14 Thus, we performed a co-immunoprecipitation (co-IP) assay using antibodies against p50 and the HA tag of the dnHMGA1 transgene. The antibody to p50 was cross-linked to protein A/G agarose beads and incubated with nuclear protein extracts from mouse vascular SMCs. The precipitated proteins were separated by SDS-PAGE for Western blot analysis using an antibody targeted against the HA tag of dnHMGA1. As seen in the pre-IP nuclear lysates, the dnHMGA1 protein was present in cells from Tg but not from WT mice (Fig. 2C) . Also, the dnHMGA1 protein was present in the p50 antibody-immunoprecipitated proteins from Tg cells, but not from WT cells (Fig. 2C) . There was no evidence of dnHMGA1 transgene in samples from IgG immunoprecipitates of TG or WT cells. Taken together, these data show that the dnHMGA1 protein is capable of interacting with p50, independent of DNA binding, and expression of dnHMGA1 attenuates transactivation of the NOS2
promoter/enhancer and levels of NOS2 mRNA.
dnHMGA1 Tg mice have less severe hypotension during exposure to E. coli LPS
To determine whether overexpression of the dnHMGA1 transgene in the vasculature of mice has a phenotype in the setting of systemic inflammation, we implanted intraarterial catheters 20, 36, 37 into the carotid arteries of WT, Tg2, and Tg1 mice. The mice were allowed to recover overnight after catheter placement, and the next morning E. coli LPS (10 mg/kg i.p.) was administered. The mice subsequently had their blood pressure assessed at serial time points. Figure 3 demonstrates that during the first 6 h after LPS, mean arterial pressure was not different between the groups. However, by 8 h, arterial pressure was significantly higher in Tg2 and Tg1 mice compared with WT mice.
Moreover, by 24 h the blood pressure stabilized in Tg2 and Tg1 mice, with no further decrease, while the arterial pressure in WT mice continued to fall and was significantly lower than Tg2 and Tg1 mice. Thus, Tg2 and Tg1 mice have a blunted hypotensive response compared with WT mice exposed to systemic LPS. While we previously showed that an MGB drug (Distamycin A) protected against severe acute hypotension during endotoxemia in mice, 20 the present study in Tg mice demonstrated that this beneficial response occurred not only early (8 h), but was also maintained throughout 24 h after administration of E. coli LPS. Next, we transitioned to a model of sepsis in mice using live E. coli bacteria.
dnHMGA1 Tg mice are protected against E. coli sepsis-induced mortality
A fibrin clot model of E. coli sepsis, as described previously, 28 was performed in Tg2 and Tg1 mice, compared with WT mice. This model allows a slow, progressive release of microorganisms. As shown in Fig. 4 , WT mice exposed to E. coli sepsis had a 37% survival at 48 hours, and Tg1 (white bar, n = 4) mice were subjected to fibrin clot-induced sepsis using E. coli as above. At 24 h, peritoneal fluid was collected and cells were analyzed for total numbers (upper panels) and percentages (%, lower panels) of neutrophils and macrophages. Data are presented as mean ± SEM. (B) WT (gray bar, n = 5) and Tg1 (white bar, n = 7) mice were subjected to fibrin clot-induced sepsis using E. coli, and at 24 h the peritoneal fluid was collected and analyzed for CFUs/ml. Data are presented as box plots, which show median values and interquartile ranges. (C) GFP-labeled E. coli were injected i.p. into WT (n = 3) and Tg1 (n = 3) mice, and after 1 h a peritoneal lavage was performed to assess neutrophil phagocytosis in vivo. Percentage of neutrophils phagocytizing bacteria are presented as mean ± SEM. NS, not significant for panels A-C
Peritoneal response to E. coli-induced sepsis in dnHMGA1 mice
We subsequently investigated the peritoneal response to fibrin clotinduced sepsis by E. coli. Figure 5A demonstrates that at 24 h after the onset of sepsis, the recruitment of innate immune cells into the peritoneal cavity was predominantly neutrophils in both WT and dnHMGA1 Tg mice. Moreover, the total numbers and percentages of neutrophils, and macrophages, were not different between the groups.
In conjunction with a similar immune response to peritoneal sepsis, there was also no difference in peritoneal bacteria (Fig. 5B) . Likewise, in vivo phagocytosis assays in WT and Tg mice revealed no differences in the percentages of neutrophils (21±3% vs. 21±7% respectively, P = 0.99, Fig. 5C ) or macrophages (21± 9% versus 11±1% respectively, P = 0.44) phagocytizing bacteria. Thus, to further understand the differences in the physiologic effects of WT and Tg mice to sepsis, we next assessed systemic inflammation.
Decreased tissue infiltration of inflammatory cells in dnHMGA1 Tg mice
The spleen is a very sensitive organ to the inflammatory effects of sepsis, resulting in injury and an alteration in cellular composition. 43, 44 Thus, we evaluated the inflammatory response and the infiltration of innate immune cells (macrophages and neutrophils) into the spleen after E. coli-induced sepsis. Compared with sham mice, there was a marked increase in macrophage infiltration into the spleens (mainly in the red pulp) of WT mice 24 h after placement of the E. coli fibrin clot (Fig. 6) . In dnHMGA1 Tg mice, there was also evidence of increased splenic macrophages after E. coli-induced sepsis compared with sham mice, however the level of macrophage infiltrates was dramatically less compared with septic WT mice (Fig. 6) . We next examined neutrophil infiltrates into spleens of WT and Tg mice 24 h after E. coli fibrin clot, compared with sham mice. The dramatic increase in splenic neutrophils in WT mice after the onset of E. coli sepsis was significantly less in dnHMGA1 Tg mice (Fig. 7) . This reduction of splenic neutrophils in dnHMGA1 mice was analogous to the reduction of splenic macrophages in dnHMGA1 mice compared with WT mice exposed to E. coli sepsis. We also assessed neutrophils in the lungs. Similar to the spleen, an increase in lung neutrophils in WT mice was blunted in Tg mice (Fig. 8) . Collectively, these data revealed a decrease in organ inflammation in dnHGMA1 mice (involving organs both inside and outside of the peritoneum), compared with WT mice during peritoneal sepsis.
Given the reduced infiltration of macrophages and neutrophils into tissues of Tg mice compared with WT mice during E. coli sepsis,
we next assessed the levels of chemokine ligand 2 (CCL2)/monocyte chemotactic protein (MCP)-1, and C-X-C motif chemokine ligand Tg mice (Fig. 9) . 
DISCUSSION
Sepsis is defined as a dysregulated host response to infection, with evidence of organ dysfunction that carries a high rate of mortality. 48 The immune reaction to infection involves both pro-inflammatory and anti-inflammatory responses, with a balance of these processes needed to prevent collateral injury and to restore homeostasis. 49 The innate immune system is the primary line of defense against invading microbes, 49, 50 and an aberrant response can result in exaggerated inflammation and associated tissue damage and organ injury. Thus, further insights into the immune response to infection, and associated sepsis, will provide targets for novel therapeutic interventions. The aim of the present study was to further understand the role of HMGA1 in the pathophysiology of the immune response to E. coli-induced sepsis.
The balance between pro-inflammatory and anti-inflammatory mediators is often regulated at the level of gene expression, 17 In the present study, our data demonstrate that dnHMGA1 Tg mice have a blunted hypotensive response during endotoxemia (Fig. 3) , and in a microbial model of sepsis, the Tg mice have improved survival (Fig. 4) . Interestingly, innate immune cell recruitment to the peritoneal cavity (housing the E. coli fibrin clot), along with bacterial counts and phagocytosis, was not different between WT and Tg mice (Fig. 5A-C) .
Thus, we next assessed the inflammatory response in organs, both inside (spleen) and outside (lung) the peritoneum. In comparison with WT mice, 24 h after the onset of E. coli-induced sepsis the infiltration of macrophages and neutrophils into the spleen was markedly less in Tg mice (Figs. 6 and 7, respectively), as well as neutrophil infiltration into the lungs (Fig. 8) . Thus, during microbial sepsis, inflammation in critical organs was more effectively resolved in dnHMGA1 Tg mice compared with WT mice, associated with improved survival.
To further characterize the infiltration of macrophages and neutrophils into tissue during sepsis, we further assessed the levels of MCP-1 and MIP-2 in cells from Tg and WT mice. MCP-1 is a member of the C-C chemokine family, and it is known to regulate the migration and infiltration of leukocytes into tissue, with a predominant effect on monocytes, 53 which subsequently differentiate into macrophages within the inflamed tissue. MCP-1 is produced in a number of cell types, including SMCs, and during an infectious insult expression is increased, resulting in high levels of MCP-1 in plasma and inflamed tissues. 45, 46 During exposure to the inflammatory cytokines IL-1 or TNF-in vitro, SMCs harvested from dnHMGA1 Tg mice showed decreased expression of MCP-1 mRNA compared with SMCs from WT mice (Fig. 9A) . In addition, expression of the neutrophil F I G U R E 9 dnHMGA1 cells and mice have decreased expression of chemokines during exposure to imflammatory stimuli. SMCs harvested from WT or dnHMGA1 (Tg1) mice were exposed to vehicle (Veh), IL-1 (10 ng/ml), or TNF-(10 ng/ml) for various time points (as depicted). Total RNA was extracted from the cells, and levels of (A) MCP-1 and (B) MIP-2 were measured by qRT-PCR. Data are presented as mean ± SEM, n = 3 per group, with testing by one-way ANOVA (P < 0.0001). Significant comparisons; * WT versus Tg1. C) WT and Tg1 mice underwent sham (-E. coli) or fibrin clot (+E. coli) surgery. At 24 h after surgery, tissue (spleen) and plasma were collected, and the concentration of MCP-1 was assessed using a Luminex bead assay as described in the Material and Methods. Data are represented as mean ± SEM, from 3 mice per group. Analyses by one-way ANOVA (P = 0.0399, spleen; P = 0.0253, plasma). Significant comparisons for (C), *versus sham groups, †versus WT E. coli group. NS, not significant chemokine MIP-2 was similarly decreased in Tg SMCs compared with WT SMCs exposed to inflammatory cytokines (Fig. 9B) . Furthermore, during E. coli-induced sepsis in vivo, the levels of splenic and plasma MCP-1 protein were significantly increased in WT mice, however the elevated MCP-1 levels were diminished in the dnHMGA1 Tg mice (Fig. 9C) .
Previous studies have demonstrated that an absence of MCP-1 in genetically modified mice leads to increased susceptibility to systemic inflammation in models of endotoxemia and polymicrobial sepsis, compared with WT mice. 54 Moreover, in the absence of MCP-1, bacterial clearance was reduced in models of peritoneal sepsis (either polymicrobial or E. coli) and E. coli-induced pneumonia. 55 In peritoneal sepsis, MCP-1 deficient mice had decreased recruitment of monocytes to the sight of injury, and lethality correlated with impaired production of the anti-inflammatory mediator IL-10, suggesting MCP-1 played an important immunomodulatory role in controlling the balance of pro-inflammatory mediators and anti-inflammatory mediators during sepsis. 54 In contrast, in the dnHMGA1 Tg mice, the expression of IL-10
was not different from WT mice during sepsis ( Supplementary Fig. 2 ).
Interestingly, in the dnHMGA1 Tg mice, the induction of MCP-1 and MIP-2 was blunted, although the levels were still above that of sham mice (Fig. 9) . Thus, expression of dnHMGA1 was able to modulate the chemokine response with less tissue inflammation.
Since MCP-1 and MIP-2 are NK-B regulated genes, [56] [57] [58] and dnHMGA1 is able to bind to NF-B subunits but not to DNA, this may explain the attenuated expression of MCP-1 and MIP-2 in cells of dnHMGA1 Tg mice exposed to inflammatory cytokines. The decreased expression of MCP-1 may account for more than just the reduction in macrophage infiltration into the spleen (Fig. 6 ), as it has been shown that MCP-1 regulates neutrophil recruitment during E. coli infection. 59 Moreover, decreased expression of MIP-2, a chemokine critical for neutrophil recruitment, 60, 61 contributes to less infiltration of neutrophils into organs of Tg mice during peritoneal sepsis (Figs. 7 and 8).
HMGA1 is known to regulate a number of genes that have been implicated in the pathophysiology of sepsis. 17 HMGA1 plays an important role in the regulation of mouse [12] [13] [14] and human 16 NOS2 during exposure to pro-inflammatory mediators. In addition, using the minor groove binding drug Distamycin A, we were able to reduce the induction of NOS2, rather than eliminating its expression, resulting in an attenuation of hypotension and improved survival during endotoxemia. 20 A similar attenuation of NOS2 mRNA levels ( Fig. 2A) and NOS2 transactivation (Fig. 2B ) was seen when dnHMGA1 was expressed in SMCs in the presence of inflammatory cytokines. Distamycin A also suppressed the induction of P-selectin, resulting in decreased inflammation in key organs during endotoxemia. 22 This is very comparable to the chemokine response in the dnHMGA1 Tg mice during microbial sepsis, with diminished MCP-1 and MIP-2 induction, rather than elimination of expression, and Tg mice experiencing improved outcome.
The dominant negative construct, while not being able to bind to DNA, can still interact with transcription factors. As seen in Fig. 2 , the dnHMGA1 protein co-immunoprecipitates with NF-B subunit p50 in extracts from dnHMGA1 Tg SMCs, but not WT SMC. Thus, we hypothesize that one mechanism by which the dnHMGA1 transgene may function is by sequestering transcription factors from binding to DNA (for example, NF-B subunits), and altering the expression of genes (such as NOS2, MCP-1, MIP-2, and inflammatory mediators) contributing to the pathophysiologic response to microbial sepsis. 17 Taken together, our data suggest that HMGA1 is a novel modifiable pathway that may be targeted for therapeutics in sepsis.
